Global Perfusion System Databank Market Report

Global Perfusion System Databank Market Report

The Perfusion System market was valued at $1,025.6 Million in 2022, and is projected to reach $1,431.8 Million by 2031 growing at a CAGR of 3.82% from 2023 to 2031. Cardiopulmonary Perfusion System segment is expected to be the highest contributor to this market, with $488.7 Million in 2022, and is anticipated to reach $652.2 Million by 2031, registering a CAGR of 3.30%. Cell Perfusion System segment is anticipated to reach $310.7 Million by 2031 with the highest CAGR of 4.77%. Cardiopulmonary Perfusion System and Ex-Vivo Organ Perfusion System segments collectively expected to account for about 80.0% share of the Perfusion System market in 2022, with the former constituting around 47.7% share. Cell Perfusion System and Ex-Vivo Organ Perfusion System segments are expected to witness significant growth rates at a CAGR of 4.77% and 3.95% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 52.3% in the overall Perfusion System market in 2022, and is anticipated to reach 54.4% by 2031.